Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac MRI in Duchenne Muscular Dystrophy
NCT05558813Withdrawn
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2024
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Late gadolinium enhancement burden at 2 years. Planned start Nov 2024; status: withdrawn.
Beyond the preview
Go deeper on NCT05558813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05558813.